What Is C-Peptide? Levels, Testing, and Results

C-peptide is a small protein your pancreas produces in equal amounts alongside insulin. It serves as a reliable marker of how much insulin your body is actually making, which is why doctors use it to distinguish between types of diabetes, monitor pancreatic function, and investigate unexplained low blood sugar. A normal fasting level falls roughly between 0.36 and 3.61 ng/mL in healthy adults.

How Your Body Makes C-Peptide

Your pancreatic beta cells don’t produce insulin directly. They first make a larger molecule called proinsulin, which then gets cut into two pieces: the active insulin molecule and C-peptide (short for “connecting peptide”). C-peptide is a 31-amino-acid chain that originally holds the two halves of the insulin molecule together during assembly. Once the cut happens, both insulin and C-peptide are stored together and released into the bloodstream in equal amounts every time your blood sugar rises.

This one-to-one ratio is what makes C-peptide so useful. Insulin itself is tricky to measure because the liver removes about half of it before it ever reaches the rest of the body. C-peptide, by contrast, passes through the liver largely untouched and lingers in the blood much longer. That makes it a more stable, more accurate snapshot of what your pancreas is doing at any given moment.

Why Doctors Order a C-Peptide Test

The most common reason is to figure out what type of diabetes someone has, especially when the clinical picture isn’t clear. In type 1 diabetes, the immune system destroys beta cells, so C-peptide levels drop very low. In type 2 diabetes, the pancreas is still producing insulin (often too much of it, in fact), so C-peptide levels are normal or elevated. A fasting C-peptide at or below 0.16 nmol/L correctly identifies type 1 diabetes about 93% of the time.

Beyond classification, doctors also use C-peptide to:

  • Evaluate unexplained low blood sugar. If someone has dangerously low blood sugar alongside high insulin levels, C-peptide can reveal whether the insulin is coming from the person’s own pancreas (as with an insulinoma, a rare pancreatic tumor) or from an external source like injected insulin. Injected insulin does not come with C-peptide, so a low C-peptide with high insulin points to outside insulin use.
  • Monitor remaining beta cell function. People with type 1 diabetes sometimes retain a small amount of insulin production. Tracking C-peptide over time shows whether that residual function is declining.
  • Assess insulin resistance. Elevated C-peptide in type 2 diabetes reflects a pancreas working overtime to compensate for cells that aren’t responding well to insulin.

What Different Levels Mean

Low C-Peptide

A level below 0.25 nmol/L (about 0.75 ng/mL) strongly suggests the pancreas can no longer produce meaningful amounts of insulin. This is the hallmark of type 1 diabetes and is also seen in advanced type 2 diabetes when beta cells have become exhausted after years of overwork. Below 0.08 nmol/L, a person has absolute insulin deficiency and will require insulin therapy to survive.

Interestingly, if someone diagnosed with type 1 diabetes still has a C-peptide above 0.08 nmol/L more than three to five years after diagnosis, it raises the possibility that the diagnosis may actually be type 2 diabetes or a genetic form of diabetes called MODY.

High C-Peptide

Elevated C-peptide means the pancreas is churning out more insulin than usual. The most common cause is insulin resistance in type 2 diabetes: your cells aren’t responding efficiently to insulin, so the pancreas compensates by making more. Other causes include insulinoma (a rare insulin-producing tumor), Cushing’s syndrome, kidney failure, and low potassium levels. Certain diabetes medications that stimulate insulin release can also raise C-peptide.

The Kidney Factor

C-peptide is cleared from the blood primarily by the kidneys, which means kidney disease can artificially inflate your results. In people with end-stage kidney disease on dialysis, average C-peptide values run significantly higher than in the general population, around 4 ng/mL compared to the typical upper limit of about 3.6 ng/mL in healthy people. If you have known kidney problems, your doctor will interpret your C-peptide results with that in mind rather than comparing them to standard reference ranges.

C-Peptide May Have Its Own Biological Role

For decades, scientists considered C-peptide a metabolic byproduct with no function of its own. That view has changed. Animal studies show that replacing C-peptide in insulin-deficient animals improves nerve function, slowing the nerve damage that causes numbness and pain in the hands and feet of people with type 1 diabetes. In these studies, C-peptide-treated animals showed less nerve fiber degeneration, healthier nerve insulation, and better nerve conduction speed.

C-peptide also appears to protect the kidneys. In animal models of type 1 diabetes, C-peptide replacement reduced the excessive kidney filtering, protein leakage into urine, and structural scarring that characterize early diabetic kidney disease. It seems to do this partly by dialing down inflammatory signaling that drives abnormal tissue buildup in the kidney’s filtering units. These findings haven’t yet translated into approved therapies for humans, but they suggest C-peptide’s absence in type 1 diabetes may contribute to complications beyond what insulin replacement alone can address.

How the Test Works

A C-peptide test is a simple blood draw. Fasting tests are most common, though stimulated tests (where you drink a sugary solution or receive an injection before the blood draw) can reveal how well your beta cells respond to a challenge. Results are reported in different units depending on the lab: nmol/L, pmol/L, or ng/mL. To convert between them, 1 nmol/L equals 3 ng/mL. This inconsistency between labs can cause confusion, so it’s worth noting which unit your results are in before comparing them to reference values you find online.

Your results are most meaningful when interpreted alongside your blood sugar at the time of the draw. A C-peptide level that looks “normal” during high blood sugar might actually indicate the pancreas isn’t keeping up. Context matters more than the number alone.